Interferon Gamma as Adjuvant Therapy for Pulmonary Atypical Mycobacteriosis
Author Information
Author(s): Milanés-Virelles María T, García-García Idrian, Santos-Herrera Yamilet, Valdés-Quintana Magalys, Valenzuela-Silva Carmen M, Jiménez-Madrigal Gaspar, Ramos-Gómez Thelvia I, Bello-Rivero Iraldo, Fernández-Olivera Norma, Sánchez-de la Osa Reinaldo B, Rodríguez-Acosta Carmen, González-Méndez Lidia, Martínez-Sánchez Gregorio, López-Saura Pedro A, the MACGAM Study Group
Primary Institution: Benéfico Jurídico Hospital, Havana, Cuba
Hypothesis
Does interferon gamma improve treatment outcomes in patients with pulmonary atypical Mycobacteriosis when used as an adjuvant to chemotherapy?
Conclusion
Interferon gamma is effective and well tolerated as an adjuvant therapy in patients with pulmonary atypical Mycobacteriosis, leading to better clinical outcomes compared to placebo.
Supporting Evidence
- 72% of patients treated with interferon gamma were complete responders compared to 36% in the placebo group.
- Patients in the interferon group showed earlier improvement in respiratory symptoms.
- Only 11.1% of patients in the interferon group died compared to 35.7% in the placebo group.
Takeaway
This study shows that giving interferon gamma along with antibiotics helps people with a lung infection caused by unusual bacteria feel better faster and live longer.
Methodology
A randomized, double-blind, placebo-controlled trial was conducted with patients receiving either interferon gamma or placebo alongside standard antibiotic treatment.
Potential Biases
Potential bias due to the study being conducted in a single country and the specific patient population.
Limitations
The study had a small sample size and was limited to specific hospitals in Cuba.
Participant Demographics
Patients were predominantly Cuban, with an average age of 60 years, 75% men, and 84% white.
Statistical Information
P-Value
0.037
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website